NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

CureBay Acquires Saveo's Pharmaceutical Distribution Business

CureBay, a rural healthtech startup, has made a strategic acquisition in the healthtech space. The company has acquired the pharmaceuticals distribution business of Saveo, a B2B health marketplace.

According to Priyadarshi Mohapatra, founder and chief executive of CureBay, the acquisition strengthens the company's presence in the healthtech industry. This move is expected to enhance CureBay's capabilities in delivering healthcare services to rural areas.

The acquisition details remain undisclosed. However, this strategic move positions CureBay as a key player in the healthtech sector, with a growing presence in the pharmaceutical distribution business.

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

Investor Takeaway

Investors should consider CureBay's strategic expansion into rural markets through this acquisition.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.